BrainStorm to start adult stem cell trial for ALS (Reuters)

Reuters – BrainStorm Cell Therapeutics Inc received approval from Israel’s Health Ministry for a clinical trial of its adult stem cell therapy for people with amyotrophic lateral sclerosis (ALS).

Related Blogs

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter